insights_auto
0QF niyə bu qədər düşüb: 3,39%?
Ətraflı araşdırınchevron_right
0QF:ETR
Moderna Inc
168,14 €
arrow_downward
-3,39%(-5,90) 1D
2 okt, 17:35:33 GMT+2 · EUR
search
Bütün simvollar
| Simvol | Qiymət | Dəyişiklik | % Dəyişiklik |
|---|
insights_auto0QF üçün ən vacib statistik məlumatlar yaradılır...
Açın
171,12 €
Yüksək
172,16 €
Aşağı
162,60 €
Bazar kapitalizasiyası
75,86 mlrd
Ortalama həcm
33,79K
Həcm
28,98K
52 həftəlik ən yüksək
184,20 €
52 həftəlik ən aşağı
19,37 €
İşçilərin sayı
5K
Açın
171,12 €
Yüksək
172,16 €
Aşağı
162,60 €
Bazar kapitalizasiyası
75,86 mlrd
Ortalama həcm
33,79K
Həcm
28,98K
52 həftəlik ən yüksək
184,20 €
52 həftəlik ən aşağı
19,37 €
İşçilərin sayı
5K
Xəbər materialları
Veb mənbələri və xəbər partnyorlarından
Simply Wall Street
·
1 saat öncə
Moderna (MRNA) Stock Looks Too Expensive For Its Sales Story
Stocktwits
·
5 saat öncə
SLS, IBRX Stocks Draw Retail Chatter As MRNA Lands A Nasdaq-100 Spot – ‘It Will Be SLS Next’
Moomoo
·
15 saat öncə
Nike, ON Semi, Moderna, and More Stocks That Explain Today's Market -- Barrons.com
TipRanks
·
16 saat öncə
Why Did Moderna Stock Gain (MRNA) in After-Hours Trading on Thursday?
Profil
Moderna, Inc. is an American pharmaceutical and biotechnology company based in Cambridge, Massachusetts, that focuses on RNA therapeutics, primarily mRNA vaccines. These vaccines use a copy of a molecule called messenger RNA to carry instructions for proteins to produce an immune response. The company's name is derived from the terms "modified", "RNA", and "modern".
The company's commercial products are the Moderna COVID-19 vaccine sold under the brand names Spikevax and Mnexspike, a respiratory syncytial virus vaccine sold under the brand name Mresvia, and an influenza vaccine sold under the brand name Mflusiva. The company has 44 treatment and vaccine candidates, of which 37 have entered clinical trials. Candidates include possible vaccines for influenza, HIV, Epstein–Barr virus, the Nipah virus, chikungunya, human metapneumovirus, varicella zoster virus, as well as a cytomegalovirus vaccine, a Zika virus vaccine funded by the Biomedical Advanced Research and Development Authority, and three cancer vaccines.
In May 2026, Time ranked Moderna first in their list of the World's Most Impactful Companies. Wikipedia
Moderna Inc haqqında
Baş İcraçı DirektorStéphane Bancel
İşçilər4,7K
Təsis Tarixisen 2010
Baş Ofis-
Sektor-
Veb-saytmodernatx.com